[Clinical study on T-1982 (cefbuperazone) in the field of obstetrics and gynecology].
A clinical investigation on the efficacy of T-1982 (cefbuperazone), a new cephamycin antibiotic, was performed in the field of obstetrics and gynecology. T-1982 was administered to 17 cases: 6 cases of parametritis, 3 cases of endometritis after artificial abortion, 3 cases of puerperal fever, 2 cases of febrile abortion, 1 case of Bartholin's abscess, 1 case of adnexitis and 1 case of infection of vaginal hematoma. Seventeen cases of these infections receiving in total 6 to 20 g of T-1982 demonstrated excellent results in 8 cases and good in the remaining 9 cases. Neither side effect nor clinical test abnormality was observed. From the present study, T-1982 is considered to have excellent efficacy and safety.
D000328:Adult; D000368:Aged; D002513:Cephamycins / Q000627:therapeutic use*; D004716:Endometritis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*; D010538:Peritonitis / Q000188:drug therapy; D011247:Pregnancy; D011645:Puerperal Infection / Q000188:drug therapy
D002513:Cephamycins; C035978:cefbuperazone